Stocks / NASDAQ / RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc.

Our Opinion

RAPT Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Preclinical in vitro and in vivo studies have demonstrated that a potential inhibitor of GCN2 (an “RPT-GCN2i”) has the ability to restore T cell proliferation and function in nutrient-deprived conditions, to overcome immune suppression induced by myeloid-derived suppressor cells, and to elicit antitumor responses in animal models.” (Page 4) Read the full document

Company Description

Company Website: